Safety of Continuous Neostigmine for the Treatment of Impaired Gastrointestinal Motility in Pediatric Patients

Abstract

Get full access to this article

View all access options for this article.

References

Gfroerer

Rolle

Pediatric intestinal motility disorders. World J Gastroenterol. 2015;21:9683-9687. doi:10.3748/wjg.v21.i33.9683

Chumpitazi

Nurko

Pediatric gastrointestinal motility disorders: challenges and a clinical update. Gastroenterol Hepatol (N Y). 2008;4:140-148.

Lopez

Botran

Garcia

, et al. Constipation in the critically ill child: frequency and related factors. J Pediatr. 2015;167:857-861. doi:10.1016/j.jpeds.2015.06.046

Elsner

Smith

Ensor

CR.

Intravenous neostigmine for postoperative acute colonic pseudo-obstruction. Ann Pharmacother. 2012;46:430-435. doi:10.1345/aph.1Q515

Mouchli

Camilleri

Lee

, et al. Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation. Neurogastroenterol Motil. 2016;28:871-878. doi:10.1111/nmo.12786

Fleming

Thompson

Stevens

, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377:1011-1018. doi:10.1016/S0140-6736(10)62226-X

Gonzalez

Lopez-Herce

Garcia

Botrán

Solana

Urbano

Neostigmine in the treatment of refractory constipation in critically ill children. J Pediatr Gastroenterol Nutr. 2011;53:224-226. doi:10.1097/MPG.0b013e3182187bab